October 7, 2016

October 07, 2016

Brentuximab Vedotin
OncLive – Oct. 6
Frederick L. Locke, MD: As always, we have to determine the safety and then see if it affects efficacy. But, there’s clearly room for improvement in Hodgkin’s lymphoma and peripheral T-cell lymphomas, where brentuximab is utilized, so a combination with checkpoint inhibitors make sense.

FDA splits on Naloxone dose
Medpage Today – Oct. 6
David Craig, PharmD, of the Moffitt Cancer Center in Tampa, Fla., said there wasn't enough evidence "that the current dose is ineffective, and indeed the majority of the data say it was effective. I would hate to move away from what's most effective."

Bucs’ Louis Murphy helps kids understand breast cancer as part of Moffitt program
TBO.com/Tampa Bay Times – Oct. 6
On Tuesday, Murphy took his mother’s story to the Moffitt McKinley Outpatient Center and shared it with members of the Junior Buccaneers football league as part of the Moffitt Cancer Center’s Healthy Kidz Go Pink program.

Day care facility at Moffitt Cancer Center closing; here are some options for nervous parents
Tampa Bay Times – Oct. 6
Moffitt Cancer Center has announced it is shutting down its day care center at the end of the year while it builds a new and bigger facility, putting the families of roughly 90 children in limbo as they seek alternate arrangements.

Investment in project grows
The Journal Gazette – Oct. 6
Among the cancer care providers with similar philosophies are Cancer Treatment Centers of America’s Atlanta location; Duke University; and Moffitt Cancer Center in Tampa, Florida, Sharma said after the formal remarks.

North Tampa Renaissance Begins with Fowler Avenue Makeover
WTSP – Oct. 4
The group has support from five globally-recognized institutions that call North Tampa home including The University of South Florida, Busch Gardens, Moffitt Cancer Center, Florida Hospital, and RD Management. 

Anti-CD20 Antibodies
OncLive – Oct. 4
Frederick L. Locke, MD: One setting where we’ve utilized ofatumumab therapy is in combination with rituximab as a bridge to allogeneic transplant for CLL patients with really refractory disease. In that setting, it seems to at least hold patients, or get them enough of a response, to get the allograft in.

Moffitt’s next big thing—a new building
Tampa Bay Business Journal – Oct. 4
Moffitt Cancer Center plans to construct a clinical support building as it works to keep pace with the needs of the aging Florida population. The cancer center isn’t saying much yet about the new structure, which was disclosed in an Oct. 3 report from Moody’s Investors Service.

Cathy Hayes getting by with a lot of help from her friends
Winter Haven News Chief – Oct. 4
The small lump she could feel was invasive ductal carcinoma, abnormal cancer cells that escaped her ducts and lodged elsewhere in her breast. Invasive ductal carcinoma is the most common type of cancer, said Dr. Nazanin Khakpour, Hayes’ surgical oncologist at Moffitt Cancer Center in Tampa. 

PHP attacks ocular melanoma
KLAS – Oct. 3
Now she is in this operating room trying percutaneous hepatic perfusion or PHP. Jonathan Zager, M.D., a surgical oncologist at Moffitt Cancer Center in Tampa, Florida, has done this procedure on about 60 patients. “I think it is a breakthrough treatment,” said Dr. Zager.

A shot in the dark
Delta Sky Magazine – October 2016 (Page 40)
“One of the more popular targets in breast cancer is a protein called HER2, which is normally present when breast ducts are growing during pregnancy,” explains Dr. Brian Czerniecki of Moffitt Cancer Center in Tampa.

Lane Ranger: $600 million raised in 30 years of specialty plates
Ocala Star Banner – Oct. 2
Plates dedicated to fallen law enforcement and featuring the Florida Sheriff’s Association, American Legion, Moffitt Cancer Center, Big Brothers/Big Sisters and Keiser University were made available for the first time in 2015 and the DMV recently announced the redesign of the Animal Friends plate, which promotes neutering and spaying of pets.

NCI’s Care Delivery Research Program Seeks to Involve Scientists from Other Fields
Cancer Letter – Sept. 30
The use of ‘healthcare delivery research’ in the name of the program was intended to signal an interest in adding to the richness of traditional health services research by involving scientists from other fields whose work would be applicable to cancer care delivery settings,” said Jacobsen, who was most recently the associate center director for population science at the Moffitt Cancer Center.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.